This inventor holds 1 USPTO granted patent. Top assignee: Korea United Pharm, Inc.. Active years: 2023.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2023
Title: Youngchul Kim: Innovator in Breast Cancer Treatment
Introduction
Youngchul Kim is a prominent inventor based in Gwangju, South Korea. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of breast cancer. His innovative approach focuses on utilizing specific compounds to combat this prevalent disease.
Latest Patents
Youngchul Kim holds a patent for a pharmaceutical composition that comprises 2,4,6-trihydroxyacetophenone (THA) as an active ingredient for treating breast cancer. This composition is designed to prevent, alleviate, or treat breast cancer by inhibiting the activity of polo-like kinase 1 (PlK1). His work in this area represents a promising advancement in cancer treatment methodologies.
Career Highlights
Currently, Youngchul Kim is associated with Korea United Pharm, Inc., where he continues to develop innovative solutions in the pharmaceutical industry. His dedication to research and development has positioned him as a key figure in the fight against breast cancer.
Collaborations
Throughout his career, Youngchul Kim has collaborated with notable colleagues, including Keon Wook Kang and Kwang-Seok Oh. These partnerships have fostered a collaborative environment that enhances the potential for groundbreaking discoveries in the field.
Conclusion
Youngchul Kim's contributions to breast cancer treatment through his innovative patent highlight his commitment to improving healthcare outcomes. His work exemplifies the vital role of inventors in advancing medical science and providing hope for patients worldwide.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile